European Archives - Page 372 of 899 - European Medical Journal

Continue
EMJ 6.1 Feature Image
11 Mins
23rd March 2021

Addressing the Unmet Need in Treatment of Nonmelanoma Skin Cancers: Interviews with Two Key Opinion Leaders

Nonmelanoma skin cancers (NMSC) are a diverse group of cutaneous malignancies and are the most common forms of human neoplasia worldwide…
EMJ 6.1 Feature Image
15 Mins
23rd March 2021

The Treatment Landscape of Atopic Dermatitis: Interviews with Three Consultant Dermatologists

Atopic dermatitis (AD), sometimes referred to as ‘atopic eczema’, is a common, chronic, pruritic, Type II inflammatory skin disease which is associated…
8 Mins
23rd March 2021

Is CD37-Targeted Therapy a Viable Alternative in the Treatment of Diffuse Large B-cell Lymphoma? Interviews with Two Key Opinion Leaders

Diffuse large B-cell lymphoma (DLBCL) is an aggressive lymphoma and the most frequent non-Hodgkin lymphoma (NHL) in adults, accounting for 30–40%…
12 Mins
23rd March 2021

Transient Cutaneous Alterations of the Newborn

At birth, the skin of the newborn suddenly comes into contact with the extrauterine world: a dry and aerobic environment.1 Newborn skin is 40–60%…
EMJ 6.1 Feature Image
3 Mins
23rd March 2021

Rare 2030 Final Policy Conference: Summary of the Recommendations of the Rare 2030 Foresight Study

IMPROVING the lives of people living with a rare disease in Europe has been an overarching aim of the Rare 2030 Foresight Study, a two-year study…
7 Mins
22nd March 2021

Performance of Different Criteria Sets for Inflammatory Back Pain in Radiographic

It is important to recognise inflammatory back pain (IBP) for early diagnosis of ankylosing spondylitis (AS). The aims of this study were to develop….
1 Mins
19th March 2021

Can Blocking Nef Proteins Treat Immunodeficiency in HIV?

IMMUNODEFIENCY in patients with HIV may be counteracted by drugs that block protein kinases, according to a new study carried out by researchers at the…
1 Mins
19th March 2021

Advanced CAR T-Cell Therapy for Multiple Myeloma

PROMISING results of a newly advanced chimeric antigen receptor (CAR) T-cell therapy showed that more than triple the period remission for multiple myeloma.
12 Mins
19th March 2021

An Interview with Major (Retd) Sally Orange

Sally Orange, | Physiotherapist | Endurance Runner | Mental Health Champion
19th March 2021

EMJ Podcast: Decisions, Development, and Devices

Dr. Brian Dunkin, Chief Medical Officer, Boston Scientific, explores the advancements in minimally invasive surgery, reflects on the growth of telemedicine, and considers the science behind recruitment and embedding culture within organisations.